| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | -7.5% |
| Cost of Revenue | $690K | +5.4% |
| Gross Profit | $610K | -18.7% |
| R&D Expense | $0 | — |
| SG&A Expense | $488K | +1.5% |
| Operating Income | -$1.6M | -27.3% |
| Pre-tax Income | $278K | +108.1% |
| Net Income | $298K | +108.7% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | +187.4% |
| Accounts Receivable | $693K | +160.8% |
| Inventory | $462K | -17.1% |
| Current Assets | $2.6M | +78.9% |
| Total Assets | $6.4M | +56.0% |
| Current Liabilities | $6.9M | -29.8% |
| Total Liabilities | $8.2M | -28.2% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.6M | -78.5% |
| Investing Cash Flow | -$1.5M | — |
| Financing Cash Flow | $4.8M | +162.8% |
| Stockholders' Equity |
| -$1.7M |
| +76.5% |